First, we confirmed CpG sites associated with AD in previous studies but in different brain regions, located in genes such as ANK1, MYOC, and RHBDF2. Additionally, we detected new associations (e.g., GPR56). This evidence concerns the gene RHBDF2 and Alzheimer disease.